PDL.F · PDL BioPharma, Inc
-
-
| Exchange | F |
|---|---|
| CurrencyCode | EUR |
| ISIN | None |
| Sector | Healthcare |
| Industry | Biotechnology |
| Market Cap | 227M |
|---|---|
| PE Ratio | 440.67 |
| Target Price | None |
| Dividend Yield | 0.0% |
| Beta | 1.09 |
ABOUT
PDL BioPharma, Inc
PDL BioPharma, Inc. manages various patents in the United States and internationally. The company's patents cover humanization of antibodies. It also offers notes and other long-term receivables services, as well as engages in the equity investment activities. The company was formerly known as Protein Design Labs, Inc. and changed its name to PDL BioPharma, Inc. in 2006. PDL BioPharma, Inc. was founded in 1986 and is headquartered in Incline Village, Nevada.
Learn More